{"id":"https://openalex.org/W4367602591","doi":"https://doi.org/10.1158/1557-3125.ras23-pr03","title":"Abstract PR03: Cooperative anti-tumor effects of combined inhibition of KRASG12C plus autophagy in preclinical models of KRASG12C-driven lung cancer","display_name":"Abstract PR03: Cooperative anti-tumor effects of combined inhibition of KRASG12C plus autophagy in preclinical models of KRASG12C-driven lung cancer","publication_year":2023,"publication_date":"2023-05-01","ids":{"openalex":"https://openalex.org/W4367602591","doi":"https://doi.org/10.1158/1557-3125.ras23-pr03"},"language":"en","primary_location":{"id":"doi:10.1158/1557-3125.ras23-pr03","doi":"https://doi.org/10.1158/1557-3125.ras23-pr03","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1557-3125.ras23-pr03","pdf_url":null,"source":{"id":"https://openalex.org/S192067876","display_name":"Molecular Cancer Research","issn_l":"1541-7786","issn":["1541-7786","1557-3125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005324538","display_name":"Phaedra C. Ghazi","orcid":"https://orcid.org/0000-0002-0884-9442","observed_orcids":["https://orcid.org/0000-0002-0884-9442"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Phaedra C. Ghazi","raw_affiliation_strings":["1University of Utah, Salt Lake City, UT,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Utah, Salt Lake City, UT,","institution_ids":["https://openalex.org/I223532165"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080566114","display_name":"Conan Grant Kinsey","orcid":"https://orcid.org/0000-0001-5614-8627","observed_orcids":["https://orcid.org/0000-0001-5614-8627"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Conan Kinsey","raw_affiliation_strings":["1University of Utah, Salt Lake City, UT,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Utah, Salt Lake City, UT,","institution_ids":["https://openalex.org/I223532165"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056952545","display_name":"Madhumita Jagannathan\u2010Bogdan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127537","display_name":"Deciphera Pharmaceuticals (United States)","ror":"https://ror.org/038hbfs18","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127537"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Madhumita Bogdan","raw_affiliation_strings":["2Deciphera Pharmaceuticals Inc, Lawrence, KS"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Deciphera Pharmaceuticals Inc, Lawrence, KS","institution_ids":["https://openalex.org/I4210127537"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111867939","display_name":"Bryan D. Smith","orcid":"https://orcid.org/0009-0002-7666-7517","observed_orcids":["https://orcid.org/0009-0002-7666-7517"]},"institutions":[{"id":"https://openalex.org/I4210127537","display_name":"Deciphera Pharmaceuticals (United States)","ror":"https://ror.org/038hbfs18","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127537"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bryan D. Smith","raw_affiliation_strings":["2Deciphera Pharmaceuticals Inc, Lawrence, KS"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Deciphera Pharmaceuticals Inc, Lawrence, KS","institution_ids":["https://openalex.org/I4210127537"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103397917","display_name":"Daniel Lee Flynn","orcid":"https://orcid.org/0000-0002-3752-7370","observed_orcids":["https://orcid.org/0000-0002-3752-7370"]},"institutions":[{"id":"https://openalex.org/I4210127537","display_name":"Deciphera Pharmaceuticals (United States)","ror":"https://ror.org/038hbfs18","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127537"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel L. Flynn","raw_affiliation_strings":["2Deciphera Pharmaceuticals Inc, Lawrence, KS"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Deciphera Pharmaceuticals Inc, Lawrence, KS","institution_ids":["https://openalex.org/I4210127537"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5003652463","display_name":"Martin McMahon","orcid":"https://orcid.org/0000-0003-2812-1042","observed_orcids":["https://orcid.org/0000-0003-2812-1042"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Martin McMahon","raw_affiliation_strings":["1University of Utah, Salt Lake City, UT,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Utah, Salt Lake City, UT,","institution_ids":["https://openalex.org/I223532165"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"21","issue":"5_Supplement","first_page":"PR03","last_page":"PR03"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10587","display_name":"Autophagy in Disease and Therapy","score":0.9101999998092651,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10587","display_name":"Autophagy in Disease and Therapy","score":0.9101999998092651,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.03400000184774399,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.02969999983906746,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/kras-g12c","display_name":"KRAS G12C","score":0.8420000076293945},{"id":"https://openalex.org/keywords/lung-cancer","display_name":"lung cancer","score":0.9200000166893005},{"id":"https://openalex.org/keywords/autophagy","display_name":"autophagy","score":0.9139999747276306},{"id":"https://openalex.org/keywords/sotorasib","display_name":"sotorasib","score":0.8579999804496765},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8050000071525574},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.6169999837875366},{"id":"https://openalex.org/keywords/liver-kinase-b1","display_name":"LKB1","score":0.8999999761581421},{"id":"https://openalex.org/keywords/ampk","display_name":"AMPK","score":0.7200000286102295},{"id":"https://openalex.org/keywords/autophagic-flux","display_name":"autophagic flux","score":0.8510000109672546},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.3440000116825104},{"id":"https://openalex.org/keywords/xenograft-models","display_name":"xenograft models","score":0.7329999804496765},{"id":"https://openalex.org/keywords/hydroxychloroquine","display_name":"hydroxychloroquine","score":0.6359999775886536},{"id":"https://openalex.org/keywords/lysosomal-inhibitors","display_name":"lysosomal inhibitors","score":0.492000013589859},{"id":"https://openalex.org/keywords/nutrient-sensing","display_name":"nutrient sensing","score":0.4699999988079071}],"concepts":[{"id":"https://openalex.org/C203522944","wikidata":"https://www.wikidata.org/wiki/Q288322","display_name":"Autophagy","level":3,"score":0.8138573169708252},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.7430410981178284},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6920780539512634},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5843501687049866},{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.49901294708251953},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.482723206281662},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.4654947519302368},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.4481941759586334},{"id":"https://openalex.org/C2781249067","wikidata":"https://www.wikidata.org/wiki/Q17142288","display_name":"MEK inhibitor","level":4,"score":0.4469677805900574},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.31940412521362305},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.24704018235206604},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.22396990656852722},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.15998592972755432},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1594705879688263},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.13240987062454224},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.11186262965202332},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.09450554847717285},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1557-3125.ras23-pr03","doi":"https://doi.org/10.1158/1557-3125.ras23-pr03","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1557-3125.ras23-pr03","pdf_url":null,"source":{"id":"https://openalex.org/S192067876","display_name":"Molecular Cancer Research","issn_l":"1541-7786","issn":["1541-7786","1557-3125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9476000070571899,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4393095409","https://openalex.org/W4391792415","https://openalex.org/W4307910496","https://openalex.org/W4282981218","https://openalex.org/W7148890915","https://openalex.org/W7055241445","https://openalex.org/W4403410113","https://openalex.org/W4415444762","https://openalex.org/W6902592469","https://openalex.org/W4200076833"],"abstract_inverted_index":{"Abstract":[0],"Approximately":[1],"25%":[2],"of":[3,28,34,43,47,54,63,103,116,152,162,169,203,230,240,260,335,351,358,383,397,403,410,434,437,444,451],"lung":[4,16,48,136,241,268,322,329,385,405,446],"cancers":[5,406],"are":[6,276],"driven":[7],"by":[8,200,278],"mutationally-activated":[9],"KRAS.":[10],"A":[11],"major":[12,66],"obstacle":[13],"in":[14,40,68,113,142,176,253,258,320,361,369,387,399,441],"treating":[15],"cancer":[17,88,137,192,242,269,323,330,386,447],"is":[18,127,294,315,390],"resistance":[19,58,282],"to":[20,59,79,93,144,172,184,194,221,227,234,283,299,366,392,407],"current":[21],"therapeutic":[22],"treatments.":[23],"The":[24],"recent":[25],"FDA":[26],"approval":[27],"sotorasib,":[29],"a":[30,37,156,218,255,295,346],"direct":[31,60],"pharmacological":[32,61],"inhibitor":[33,161,348],"KRASG12C,":[35],"marks":[36],"critical":[38],"milestone":[39],"the":[41,51,70,122,163,201,223,290,356,395,400,452],"treatment":[42,145,151,343],"this":[44,326],"important":[45],"subset":[46],"cancer.":[49,120],"However,":[50,121,308],"twin":[52],"problems":[53],"primary":[55],"or":[56,118,250,349],"acquired":[57],"inhibition":[62,102,229,436],"KRASG12C":[64,147,235,347,438],"remain":[65],"obstacles":[67],"sustaining":[69],"deepest":[71],"and":[72,159,263,281],"most":[73],"durable":[74],"patient":[75],"responses.":[76],"In":[77,286],"response":[78,143,402],"cellular":[80],"stresses":[81],"such":[82,153,207,214],"as":[83,208,215,226,298],"RAS":[84,104],"pathway-targeted":[85,408],"therapeutics,":[86],"RAS-mutated":[87],"cells":[89,138,154,193,233],"have":[90,248,376],"been":[91,198],"demonstrated":[92],"increase":[94,139],"autophagy,":[95,170],"an":[96],"intracellular":[97],"recycling":[98],"pathway.":[99],"Moreover,":[100,149],"combined":[101,150,435],"pathway":[105,306],"signaling":[106,292,353],"plus":[107,439],"autophagy":[108,126,188,212,231,319,359,401,440],"had":[109],"potent":[110,160],"anti-tumor":[111,174,432],"effects":[112,175,433],"preclinical":[114,442],"models":[115,382,443],"melanoma":[117],"pancreatic":[119],"mechanism(s)":[123,357],"underlying":[124],"treatment-induced":[125],"not":[128],"well":[129],"understood.":[130],"Here,":[131],"we":[132,375],"demonstrate":[133],"that":[134,313,355],"KRASG12C-driven":[135,321,328,362,384,404,445],"autophagic":[140,301,340],"flux":[141,302,341],"with":[146,155,244,266,333,344],"inhibitors.":[148],"specific,":[157],"selective":[158,211],"ULK1/2":[164],"protein":[165,256],"kinases,":[166],"master":[167],"regulators":[168],"led":[171],"superior":[173],"human":[177],"cell":[178,331],"line":[179],"xenograft":[180],"models.":[181],"Previous":[182],"work":[183],"understand":[185],"why":[186,228],"inhibiting":[187],"sensitizes":[189,232],"KRAS":[190,245,305,371,412],"mutant":[191],"targeted":[195],"therapy":[196],"has":[197],"confounded":[199],"use":[202],"non-specific":[204],"lysosomal":[205],"inhibitors":[206,350],"hydroxychloroquine.":[209],"Using":[210],"inhibitors,":[213],"ULK1/2i,":[216],"provides":[217],"unique":[219],"opportunity":[220],"investigate":[222,394],"precise":[224],"mechanism":[225,297],"inhibition.":[236,307],"Additionally,":[237],"about":[238],"30%":[239],"patients":[243],"mutations":[246,252],"also":[247,272],"deletions":[249],"inactivating":[251],"LKB1,":[254],"involved":[257],"regulation":[259],"nutrient":[261],"sensing":[262],"autophagy.":[264],"Patients":[265],"KRAS-mutated":[267],"whose":[270],"tumors":[271],"lack":[273],"LKB1":[274,314,336,389,398],"expression":[275,337],"characterized":[277],"aggressive":[279],"behavior":[280],"standard":[284],"treatment.":[285],"other":[287,370],"KRAS-driven":[288],"cancers,":[289],"LKB1>AMPK>ULK1":[291],"axis":[293],"proposed":[296],"how":[300],"increases":[303],"following":[304],"our":[309],"preliminary":[310],"data":[311],"suggests":[312],"dispensable":[316],"for":[317],"sotorasib-induced":[318],"cells.":[324],"To":[325],"end,":[327],"lines":[332],"loss":[334],"significantly":[338],"increased":[339],"after":[342],"either":[345],"RAF>MEK>ERK":[352],"suggesting":[354],"induction":[360],"may":[363],"be":[364],"different":[365],"those":[367],"detected":[368],"mutated":[372],"cancers.":[373],"Consequently,":[374],"generated":[377],"new":[378],"genetically":[379],"engineered":[380],"mouse":[381],"which":[388],"silenced":[391],"further":[393],"role":[396],"blockade":[409],"oncogenic":[411],"signaling.":[413],"Citation":[414],"Format:":[415],"Phaedra":[416],"C.":[417],"Ghazi,":[418],"Conan":[419],"Kinsey,":[420],"Madhumita":[421],"Bogdan,":[422],"Bryan":[423],"D.":[424],"Smith,":[425],"Daniel":[426],"L.":[427],"Flynn,":[428],"Martin":[429],"McMahon.":[430],"Cooperative":[431],"[abstract].":[448],"In:":[449],"Proceedings":[450],"AACR":[453],"Special":[454],"Conference:":[455],"Targeting":[456],"RAS;":[457],"2023":[458],"Mar":[459],"5-8;":[460],"Philadelphia,":[461],"PA.":[462],"Philadelphia":[463],"(PA):":[464],"AACR;":[465],"Mol":[466],"Cancer":[467],"Res":[468],"2023;21(5_Suppl):Abstract":[469],"nr":[470],"PR03.":[471]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2023-05-02T00:00:00"}